Post-effective amendment to a registration statement that is not immediately effective upon filing

Marketable Securities

v3.20.4
Marketable Securities
2 Months Ended 12 Months Ended
Oct. 31, 2020
Aug. 31, 2020
Marketable Securities [Abstract]    
Marketable Securities

20.        Marketable Securities

 

The components of Marketable Securities were as follows:

 

 

Cost Basis 

$

 

 

Unrealized

 Gains $

 

 

Unrealized

Losses $

 

 

Total

$

August 31, 2020

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

56,250

 

 

 

9,997

 

 

 

(38,584 )

 

 

 

Total

 

 

56,250

 

 

 

9,997

 

 

 

(46,926 )

 

 

19,321

November 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock

 

 

56,250

 

 

 

24,410

 

 

 

 

 

 

 

Total

 

 

56,250

 

 

 

34,407

 

 

 

(46,926

)

 

 

43,731

 

Unrealized losses from common stock are due to market price movements. Management does not believe any remaining unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence. The COVID-19 pandemic has caused significant market turbulence and it is possible that our evaluation will change dependant upon new information as it arises.

19.        Marketable Securities

 

The components of Marketable Securities were as follows:

 

 

 

Cost Basis 

$

 

 

Unrealized

 Gains $

 

 

Unrealized

Losses $

 

 

Total

$

 

August 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

81,250

 

 

 

9,335

 

 

 

(12,124 )

 

 

   

Total

 

 

81,250

 

 

 

9,335

 

 

 

(26,973 )

 

 

63,612  

August 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

56,250

 

 

 

9,997

 

 

 

(38,584

)

 

 

   

Total

 

 

56,250

 

 

 

9,997

 

 

 

(46,926

)

 

 

19,321  

 

We realized an $18,198 loss and received $6,802 in net proceeds on the sale of marketable securities.

Unrealized losses from common stock are due to market price movements. Management does not believe any remaining unrealized losses represent other-than-temporary impairments based on our evaluation of available evidence.